RP
Therapeutic Areas
OssiFi Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Sclerostin Small Molecule Inhibitor | Neurogenic Low Back Pain, Fracture Repair, Fracture Prevention/Osteoporosis | Pre-clinical |
| Smart Tissue Scaffold | Bone Repair (Device) | Product Development |
Leadership Team at OssiFi Therapeutics
DL
Debra L. Ellies, Ph.D.
CEO & Chairwoman
RL
Reid Leonard, Ph.D.
Corporate Development
FS
F. Scott Kimball, Ph.D.
Head of Discovery
SP
Steven Peckham, Ph.D.
Product Development, Smart Tissue Scaffold
NS
Niels Svenstrup, Ph.D.
Product Development, Osteoporosis